01.03.2018 • News

Trinseo Opens Pilot Plant, Raises S-SBR Capacity at German Site

Trinseo opens a new pilot plant and raises solution-styrene-butadiene rubber...
Trinseo opens a new pilot plant and raises solution-styrene-butadiene rubber (S-SBR) capacity at Schkopau, Germany. © digitalconsumator/Shutterstock

US performance materials and plastics company Trinseo marked the opening of its new pilot plant and solution-styrene-butadiene rubber (S-SBR) capacity expansion at Schkopau, Germany. The production expansion adds 50,000 t/y of S-SBR capacity at the site and increases the company’s global production by 33%.

Trinseo said the growth was driven by increasing global demand for S-SBR as well as the need to ensure faster innovation cycles for the performance tire market. Most of the firm's S-SBR production goes into the tire industry, which is continually improving in the areas of speed, innovation and reliability.

“With this plant, Trinseo has the ability to react faster to customer demands and enable them to become technological leaders,” said Hayati Yarkadas, SVP and business president at Trinseo. “The new pilot plant and capacity expansion is consistent with our goal of increasing EBITDA by $100 million in our Latex Binders, Synthetic Rubber, and Performance Plastics segments from 2016 to 2019.”

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read